Answer
Ilumetri (tildrakizumab) is contraindicated in hypersensitivity to tildrakizumab or any excipient and in clinically important active infection, such as active tuberculosis.
Sources for this answer
- Ilumetri 100 mg solution for injection in pre-filled syringeAlmirall Limited · emc · SmPC §4.3 Contraindications · Version 6Document updated
Sources checked